NEW YORK, Sept. 5, 2022 (GLOBE NEWSWIRE) — Why:Rosen Law Firm, a global investor rights law firm, reminds those who purchase Kiromic BioPharma, Inc. (NASDAQ: KRBP) securities: (i) pursuant to and/or traceable to the Company on or about July 2, 2021 and is providing related information Documents pending an initial public offering (“IPO”) and/or (ii) during the period from June 25, 2021 to August 13, 2021, both dates inclusive (the “Class Period”); October 4, 2022 as Lead PlaintiffDeadlines are important dates.
What: If you purchased Kiromic BioPharma securities during a class action lawsuit, you may be entitled to compensation without out-of-pocket expenses or costs incurred through a contingency fee arrangement.
Next Step:To participate in the Kiromic BioPharma fundraiser, go to https://rosenlegal.com/submit-form/?case_id=8051 Or call Mr. Phillip Kim toll free: 866-767-3653 or email:[email protected] or [email protected] Learn more about class action lawsuits. A class action lawsuit has been filed. If you wish to be a lead plaintiff, you must do so On or before October 4, 2022Apply to the court. Lead Plaintiff is the representative who directs the proceeding on behalf of the other members of the class.
Why choose ROSEN LAW:We recommend investors to select qualified legal advisors with a successful track record in senior positions. Often, the law firm issuing the notice does not have comparable experience, resources, or meaningful peer recognition.Many of these law firms do not actually conduct securities class actions, but are merely intermediaries referring clients or working with the law firm that actually files the lawsuit.Be wise when choosing a lawyer. The Law Firm of Rosen represents global investors with a focus on securities class action lawsuits and shareholder derivatives lawsuits. Law firm Rosen reaches the largest-ever settlement in a securities class action lawsuit against a Chinese company. In 2017, ISS Securities Class Action Services ranked Rosen Law Firm #1 for the number of securities class action settlements. Since 2013…
Continue to read on GlobeNewswire https://www.globenewswire.com/news-release/2022/09/05/2509634/673/zh-hant/%E9%A0%82%E5%B0%96%E6%B3%95%E5%BE%8B%E4%BA%8B%E5%8B%99%E6%89%80-ROSEN-%E9%BC%93%E5%8B%B5%E8%92%99%E5%8F%97%E8%99%A7%E6%90%8D%E7%9A%84-Kiromic-BioPharma-Inc-%E6%8A%95%E8%B3%87%E8%80%85%E5%9C%A8%E8%AD%89%E5%88%B8%E9%9B%86%E9%AB%94%E8%A8%B4%E8%A8%9F%E7%9A%84%E9%87%8D%E8%A6%81%E6%88%AA%E6%AD%A2%E6%97%A5%E6%9C%9F%E5%89%8D%E5%B0%8B%E6%B1%82%E6%B3%95%E5%BE%8B%E6%84%8F%E8%A6%8B-KRBP.html
